| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| OSCROscar Health, Inc. | 4.38B | 17.38 | 181.61 | 56.54% | -2.16% | -23.77% | 21.67% | 0.29 |
| CLOVClover Health Investments, Corp. | 1.08B | 2.54 | -28.93 | 8.77% | -3.29% | -17.11% | 3.09% | |
| ALHCAlignment Healthcare, Inc. | 4.19B | 20.92 | -31.22 | 48.25% | -0.57% | -12.86% | 3.26 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Revenue | 756.96M | 959.22M | 1.17B | 1.43B | 1.82B | 2.7B |
| Revenue Growth % | - | 0.27% | 0.22% | 0.23% | 0.27% | 0.48% |
| Medical Costs & Claims | 661.39M | 792.99M | 1.04B | 1.25B | 1.62B | 2.41B |
| Medical Cost Ratio % | - | - | - | - | - | - |
| Gross Profit | 95.57M | 166.23M | 128.73M | 184.28M | 201.03M | 296.69M |
| Gross Margin % | - | - | - | - | - | - |
| Gross Profit Growth % | - | 0.74% | -0.23% | 0.43% | 0.09% | 0.48% |
| Operating Expenses | 125.06M | 171.49M | 306.8M | 312.92M | 328.85M | 398.25M |
| OpEx / Revenue % | - | - | - | - | - | - |
| Depreciation & Amortization | 16.58M | 15.46M | 16.03M | 17.49M | 21.67M | 27.06M |
| Combined Ratio % | - | - | - | - | - | - |
| Operating Income | -29.48M | -5.26M | -178.07M | -128.64M | -127.82M | -101.56M |
| Operating Margin % | - | - | - | - | - | - |
| Operating Income Growth % | - | 0.82% | -32.83% | 0.28% | 0.01% | 0.21% |
| EBITDA | -12.9M | 10.2M | -162.04M | -111.15M | -106.15M | -74.49M |
| EBITDA Margin % | - | - | - | - | - | - |
| Interest Expense | 14.9M | 16.93M | 17.44M | 18.29M | 21.23M | 23.55M |
| Non-Operating Income | 351K | 732K | -229K | 2.37M | -853K | 2.95M |
| Pretax Income | -44.73M | -22.93M | -195.29M | -149.3M | -148.19M | -128.05M |
| Pretax Margin % | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 339K | -22K | 21K |
| Effective Tax Rate % | - | - | - | - | - | - |
| Net Income | -44.73M | -22.93M | -195.29M | -149.55M | -148.02M | -128.03M |
| Net Margin % | - | - | - | - | - | - |
| Net Income Growth % | - | 0.49% | -7.52% | 0.23% | 0.01% | 0.13% |
| EPS (Diluted) | -0.29 | -0.12 | -1.14 | -0.83 | -0.79 | -0.67 |
| EPS Growth % | - | 0.59% | -8.5% | 0.27% | 0.05% | 0.15% |
| EPS (Basic) | -0.29 | -0.12 | -1.14 | -0.83 | -0.79 | -0.67 |
| Diluted Shares Outstanding | 152.13M | 187.27M | 171.96M | 181.21M | 186.21M | 190.79M |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Assets | 193.44M | 338.5M | 630.89M | 633.86M | 591.88M | 782.06M |
| Asset Growth % | - | 0.75% | 0.86% | 0% | -0.07% | 0.32% |
| Total Investment Assets | 0 | 0 | 0 | 0 | 115.91M | 37.79M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 115.91M | 37.79M |
| Total Current Assets | 127.35M | 264.68M | 552.86M | 544.55M | 483.54M | 661.64M |
| Cash & Equivalents | 86.48M | 207.31M | 466.6M | 409.55M | 202.9M | 432.86M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 42.11M | 44.97M | 37.08M |
| Goodwill & Intangibles | 34.97M | 34.65M | 35.12M | 40.29M | 40.08M | 39.38M |
| Goodwill | 29.3M | 29.3M | 29.3M | 34.81M | 34.83M | 34.83M |
| Intangible Assets | 5.67M | 5.34M | 5.81M | 5.48M | 5.25M | 4.55M |
| PP&E (Net) | 27.44M | 37.03M | 38.21M | 42.99M | 61.86M | 74.96M |
| Other Assets | 3.68M | 2.15M | 4.71M | 6.04M | 6.41M | 6.09M |
| Total Liabilities | 272.15M | 307.89M | 324.84M | 394.56M | 433.81M | 681.11M |
| Total Debt | 137.96M | 154.44M | 157.59M | 164.6M | 170.79M | 329.26M |
| Net Debt | 51.47M | -52.87M | -309M | -244.95M | -32.12M | -103.6M |
| Long-Term Debt | 137.96M | 144.17M | 150.62M | 160.9M | 161.81M | 321.43M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 1.21M |
| Total Current Liabilities | 130.26M | 153.45M | 167.25M | 229.96M | 263.02M | 351.85M |
| Accounts Payable | 117.73M | 128.28M | 17.43M | 171.92M | 170.07M | 242.5M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 34.11M | 38.72M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 3.94M | 0 | 0 | 0 | 0 | 0 |
| Total Equity | -78.71M | 30.61M | 306.06M | 239.3M | 158.07M | 100.95M |
| Equity Growth % | - | 1.39% | 9% | -0.22% | -0.34% | -0.36% |
| Shareholders Equity | -78.71M | 30.61M | 306.04M | 238.13M | 156.95M | 99.85M |
| Minority Interest | 0 | 0 | 15K | 1.18M | 1.13M | 1.1M |
| Retained Earnings | -78.71M | -379.57M | -582.69M | -732.24M | -880.26M | -1.01B |
| Common Stock | 0 | 164K | 187K | 187K | 189K | 192K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on Equity (ROE) | - | -0.75% | -1.16% | -0.55% | -0.74% | -0.99% |
| Return on Assets (ROA) | -0.23% | -0.09% | -0.4% | -0.24% | -0.24% | -0.19% |
| Equity / Assets | - | - | - | - | - | - |
| Debt / Equity | - | 5.05x | 0.51x | 0.69x | 1.08x | 3.26x |
| Book Value per Share | -0.52 | 0.16 | 1.78 | 1.32 | 0.85 | 0.53 |
| Tangible BV per Share | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 9.21M | 7.56M | -78.78M | -45.43M | -59.19M | 34.77M |
| Operating CF Growth % | - | -0.18% | -11.42% | 0.42% | -0.3% | 1.59% |
| Operating CF / Revenue % | - | - | - | - | - | - |
| Net Income | -44.73M | -22.93M | -195.29M | -149.64M | -148.17M | -128.07M |
| Depreciation & Amortization | 16.58M | 15.46M | 16.03M | 17.49M | 21.67M | 27.06M |
| Stock-Based Compensation | 1.16M | 2.12M | 110.6M | 81.72M | 66.83M | 71.13M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 7.21M | 9.65M | 9.29M | 10.56M | -1.54M | 3.75M |
| Working Capital Changes | 29M | 3.25M | -19.42M | -5.55M | 2.03M | 60.89M |
| Cash from Investing | -10.24M | -16.36M | -20.82M | -28.22M | -147.26M | 39.19M |
| Capital Expenditures | -10.24M | -15.71M | -18.36M | -23.77M | -35.99M | -41.42M |
| Acquisitions | 0 | 0 | 0 | -4.04M | 0 | 0 |
| Purchase of Investments | -320K | -1.57M | -2.48M | -2.83M | -379.06M | -82.2M |
| Sale/Maturity of Investments | 325K | 825K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | 0 | 100K | -1.41M | 0 | 0 | 14K |
| Cash from Financing | 52.66M | 130.12M | 360.13M | 16.59M | 105K | 156.03M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -1.98M | -1.5M | -1.47M | 0 | 0 | -350K |
| Stock Issued | 500K | 135M | 390.6M | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 0 | 0 | 1000K | 0 | 1000K |
| Other Financing | -854K | -3.37M | -29M | -5.23M | 105K | -8.62M |
| Net Change in Cash | 51.63M | 121.33M | 260.54M | -57.05M | -206.34M | 229.99M |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 34.85M | 86.48M | 207.81M | 468.35M | 411.3M | 204.95M |
| Cash at End | 86.48M | 207.81M | 468.35M | 411.3M | 204.95M | 434.94M |
| Free Cash Flow | -1.04M | -8.15M | -97.14M | -69.2M | -95.18M | -6.65M |
| FCF Growth % | - | -6.86% | -10.92% | 0.29% | -0.38% | 0.93% |
| FCF Margin % | - | - | - | - | - | - |
| FCF per Share | -0.01 | -0.04 | -0.56 | -0.38 | -0.51 | -0.03 |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Combined Ratio | 103.9% | 100.55% | 115.25% | 108.97% | 107.01% | 103.76% |
| Medical Cost Ratio | 87.37% | 82.67% | 88.98% | 87.15% | 88.98% | 89.03% |
| Return on Equity (ROE) | - | -74.89% | -116.01% | -54.84% | -74.5% | -98.86% |
| Return on Assets (ROA) | -23.12% | -8.62% | -40.29% | -23.65% | -24.15% | -18.64% |
| Equity / Assets | -40.69% | 9.04% | 48.51% | 37.75% | 26.71% | 12.91% |
| Book Value / Share | -0.52 | 0.16 | 1.78 | 1.32 | 0.85 | 0.53 |
| Debt / Equity | - | 5.05x | 0.51x | 0.69x | 1.08x | 3.26x |
| Revenue Growth | - | 26.72% | 21.74% | 22.81% | 27.16% | 48.25% |
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Health Care, Premium | 1.12B | 1.37B | 1.67B |
| Health Care, Premium Growth | - | 22.44% | 21.55% |
| Health Care Capitation | 46.22M | 59.22M | 132.8M |
| Health Care Capitation Growth | - | 28.11% | 124.27% |
Alignment Healthcare, Inc. (ALHC) grew revenue by 48.3% over the past year. This is strong growth.
Alignment Healthcare, Inc. (ALHC) reported a net loss of $20.8M for fiscal year 2024.
Alignment Healthcare, Inc. (ALHC) has a return on equity (ROE) of -98.9%. Negative ROE indicates the company is unprofitable.
Alignment Healthcare, Inc. (ALHC) has a combined ratio of 103.8%. A ratio above 100% means claims and expenses exceed premiums.